SCHEMBL4246750

SCHEMBL4246750

O=C(O)c1cc(=O)c2ccc([N+](=O)[O-])cc2o1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.61
KDM4E B2RXH2 2/20 0.56
CSNK2A2 P19784 2/20 0.56
CSNK2B P67870 2/20 0.56
CSNK2A1 P68400 2/20 0.56
USP2 O75604 1/20 0.56
PTGS1 P23219 1/20 0.56
CSNK2A3 Q8NEV1 1/20 0.56
ALDH1A1 P00352 3/20 0.56
GPR35 Q9HC97 3/20 0.53
MEN1 O00255 1/20 0.51
MAPT P10636 1/20 0.51
KMT2A Q03164 1/20 0.51
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
CYP3A4 P08684 1/20 0.45
ALOX15 P16050 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
TNKS O95271 1/20 0.45
PARP1 P09874 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4252552 0.88 ALDH1A1 (0.60) AKR1B1KDM4ECSNK2A2CSNK2BCSNK2A1
SCHEMBL4252102 0.83 KDM4E (0.64) AKR1B1KDM4EALDH1A1MEN1MAPT
SCHEMBL4254512 0.81 AKR1B1 (0.67) AKR1B1KDM4EALDH1A1MEN1MAPT
SCHEMBL4250567 0.80 KDM4E (0.47) AKR1B1KDM4EALDH1A1MEN1MAPT
SCHEMBL4256577 0.80 AKR1B1 (0.67) AKR1B1KDM4EALDH1A1MEN1MAPT
SCHEMBL1091343 0.80 MAOA (0.51) CSNK2A2CSNK2BCSNK2A1CSNK2A3ALDH1A1
SCHEMBL4253623 0.79 MAOB (0.65) AKR1B1KDM4EALDH1A1MEN1MAPT
SCHEMBL4246734 0.79 AKR1B1 (0.52) AKR1B1KDM4EALDH1A1MEN1MAPT
SCHEMBL654558 0.77 MAOA (0.67) KDM4ECSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL31217544 0.77 MEN1 (0.55) KDM4ECSNK2A2CSNK2BCSNK2A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101497571-B Process for producing chromone compound SUMITOMO CO LTD 2012-07-04 CN disclosed
CN-1911896-B Process for producing benzopyrone compound SUMITOMO CHEMICAL CO 2010-09-15 CN disclosed
EP-2105431-A1 Process for Producing Chromone Compound Sumitomo Chemical Company, Limited (JP) 2009-09-30 EP disclosed
EP-2105432-A1 Process for Producing Chromone Compound Sumitomo Chemical Company, Limited (JP) 2009-09-30 EP disclosed
CN-101497571-A Process for producing chromone compound SUMITOMO CHEMICAL CO (JP) 2009-08-05 CN disclosed
CN-100509751-C Process for producing benzopyranone compound SUMITOMO CHEMICAL CO (JP) 2009-07-08 CN disclosed
EP-1867626-A2 Process for producing chromone compound Sumitomo Chemical Company, Limited (JP) 2007-12-19 EP disclosed
CN-1911896-A Process for producing chromone compound SUMITOMO CHEMICAL CO (JP) 2007-02-14 CN disclosed
US-20060217565-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-09-28 US disclosed
US-7094914-B2 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-08-22 US disclosed
US-20050209274-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABOTT LABORATORIES 2005-09-22 US disclosed
CN-1649824-A Process for producing benzopyranone compound SUMITOMO CHEMICAL CO (JP) 2005-08-03 CN disclosed
US-20050085664-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LMITED (JP) 2005-04-21 US disclosed
EP-1479667-A1 PROCESS FOR PRODUCING CHROMONE COMPOUND Sumitomo Chemical Company, Limited (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050085664-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL AKR1B1 237/4885KDM4E 978/4885CSNK2A2 405/4885
US-20050209274-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R AKR1B1 1927/4885KDM4E 2305/4885CSNK2A2 3854/4885
US-20060217565-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL AKR1B1 237/4885KDM4E 978/4885CSNK2A2 405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.